Literature DB >> 3669781

Influence of interferon on the growth of primary ovarian carcinoma cells in a semi-solid agar system: comparison with clinical effects of interferon therapy.

P Ling1, S Einhorn, I M Anjegård, G Brenning, N Einhorn, H Strander.   

Abstract

The sensitivity of primary human ovarian cancer cells to interferon (IFN) was studied in vitro by the use of a tumor cloning system in semi-solid agar. Tumor colonies were found in 37% (34/93) of the experiments with tumor cells from ascites and in 35% (6/17) of the experiments with solid tumors. The relative colony-forming ability could not be correlated to prior treatment. In 15 out of 18 patients the ascitic tumor cells were sensitive to IFN-alpha. Sensitivity was found in one test out of three with solid tumors. The sensitivity was dependent on the dose of IFN but could vary for the natural IFNs alpha and gamma. In seven patients the relation between in vitro and in vivo sensitivity of the tumor cells to IFN could be studied. Any correlation between in vitro and in vivo sensitivity could not be revealed in this small group of patients.

Entities:  

Mesh:

Substances:

Year:  1987        PMID: 3669781     DOI: 10.1007/bf02934944

Source DB:  PubMed          Journal:  Med Oncol Tumor Pharmacother        ISSN: 0736-0118


  12 in total

1.  Direct cloning of human ovarian carcinoma cells in agar.

Authors:  A W Hamburger; S E Salmon; M B Kim; J M Trent; B J Soehnlen; D S Alberts; H J Schmidt
Journal:  Cancer Res       Date:  1978-10       Impact factor: 12.701

2.  Interferons and the immune system.

Authors:  B R Bloom
Journal:  Nature       Date:  1980-04-17       Impact factor: 49.962

3.  Production of interferon in human leukocytes from normal donors with the use of Sendai virus.

Authors:  K Cantell; S Hirvonen; H L Kauppinen; G Myllylä
Journal:  Methods Enzymol       Date:  1981       Impact factor: 1.600

4.  Sensitivity of human ovarian carcinoma cells to interferon and other antitumor agents as assessed by an in vitro semi-solid agar technique.

Authors:  L B Epstein; J T Shen; J S Abele; C C Reese
Journal:  Ann N Y Acad Sci       Date:  1980       Impact factor: 5.691

5.  Tumor growth stimulation in vitro by interferons.

Authors:  C U Ludwig; B G Durie; S E Salmon; T E Moon
Journal:  Eur J Cancer Clin Oncol       Date:  1983-11

6.  Human leukocyte interferon therapy for advanced ovarian carcinoma.

Authors:  N Einhorn; K Cantell; S Einhorn; H Strander
Journal:  Am J Clin Oncol       Date:  1982-04       Impact factor: 2.339

7.  Review of experience with interferon and drug sensitivity testing of ovarian carcinoma in semisolid agar culture.

Authors:  L B Epstein; S G Marcus
Journal:  Cancer Chemother Pharmacol       Date:  1981       Impact factor: 3.333

8.  Primary bioassay of human tumor stem cells.

Authors:  A W Hamburger; S E Salmon
Journal:  Science       Date:  1977-07-29       Impact factor: 47.728

9.  Comparative antiproliferative efficacies of human alpha and gamma interferons.

Authors:  B Y Rubin; V Sekar; W A Martimucci
Journal:  J Gen Virol       Date:  1983-08       Impact factor: 3.891

10.  Association between human tumor colony-forming assay results and response of an individual patient's tumor to chemotherapy.

Authors:  D D Von Hoff; J Casper; E Bradley; J Sandbach; D Jones; R Makuch
Journal:  Am J Med       Date:  1981-05       Impact factor: 4.965

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.